86 related articles for article (PubMed ID: 9778675)
1. Lymphatic mapping in the treatment of breast cancer.
Cox CE; Haddad F; Bass S; Cox JM; Ku NN; Berman C; Shons AR; Yeatman T; Pendas S; Reintgen DS
Oncology (Williston Park); 1998 Sep; 12(9):1283-92; discussion 1293-4, 1297-8. PubMed ID: 9778675
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
4. Learning curves and certification for breast cancer lymphatic mapping.
Bass SS; Cox CE; Reintgen DS
Surg Oncol Clin N Am; 1999 Jul; 8(3):497-509. PubMed ID: 10448692
[TBL] [Abstract][Full Text] [Related]
5. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings].
Cserni G; Boross G; Baltás B
Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445
[TBL] [Abstract][Full Text] [Related]
6. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients.
Bertoglio S; Sandrucci S; Percivale P; Goss M; Gipponi M; Moresco L; Mussa B; Mussa A
J Surg Oncol; 2004 Mar; 85(3):166-70. PubMed ID: 14991889
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic mapping with sentinel node biopsy in pediatric patients.
Neville HL; Andrassy RJ; Lally KP; Corpron C; Ross MI
J Pediatr Surg; 2000 Jun; 35(6):961-4. PubMed ID: 10873044
[TBL] [Abstract][Full Text] [Related]
9. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
[TBL] [Abstract][Full Text] [Related]
10. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy and melanoma biology.
Essner R
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2320s-2325s. PubMed ID: 16609052
[TBL] [Abstract][Full Text] [Related]
13. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic mapping and sentinel node biopsy in breast cancer.
McIntosh SA; Purushotham AD
Br J Surg; 1998 Oct; 85(10):1347-56. PubMed ID: 9782012
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer.
Cox CE; Bass SS; McCann CR; Ku NN; Berman C; Durand K; Bolano M; Wang J; Peltz E; Cox S; Salud C; Reintgen DS; Lyman GH
Annu Rev Med; 2000; 51():525-42. PubMed ID: 10774480
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
18. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
19. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
20. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer.
Giobuin SM; Kavanagh DO; Myers E; Doherty AO; Quinn CM; Crotty T; Evoy D; McDermott E
Eur J Surg Oncol; 2009 Dec; 35(12):1257-60. PubMed ID: 19497702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
